Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C127H145ClF4N10O23S5 |
| Molecular Weight | 2451.335 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 7 |
| Charge | 0 |
| Stereo Comments | Assumed E |
SHOW SMILES / InChI
SMILES
CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCCC(=O)NCCNC(=O)C4=C(F)C(F)=C(OCC(=O)[C@H](CCCCNC(=O)CCCCC[N+]5=C(\C=C\C=C\C=C\C=C6\N(CCCCS([O-])(=O)=O)C7=C(C8=CC=CC=C8C=C7)C6(C)C)C(C)(C)C9=C5C=CC%10=CC=CC=C9%10)NC(=O)[C@H](CC%11=CC=CC=C%11)NC(=O)OCC%12=CC=CC=C%12)C(F)=C4F)C%13=C(C%14=C(C=C%13)C=C(C=C%14)S([O-])(=O)=O)C3(C)C)=C2Cl)N(CCCS(O)(=O)=O)C%15=C1C=C(C=C%15)N(CCCS(O)(=O)=O)CCCS(O)(=O)=O
InChI
InChIKey=NSTNPRUQYXIYCN-WQLOVQMRSA-N
InChI=1S/C127H145ClF4N10O23S5/c1-124(2)97-82-92(138(70-35-77-167(152,153)154)71-36-78-168(155,156)157)58-64-100(97)139(75-37-79-169(158,159)160)107(124)65-56-89-44-34-45-90(115(89)128)57-66-108-127(7,8)114-96-60-59-93(170(161,162)163)81-91(96)55-63-103(114)142(108)73-31-15-23-52-110(145)134-68-69-135-122(147)111-116(129)118(131)120(119(132)117(111)130)164-84-104(143)98(136-121(146)99(80-85-38-16-12-17-39-85)137-123(148)165-83-86-40-18-13-19-41-86)48-28-29-67-133-109(144)51-22-14-30-72-140-101-61-53-87-42-24-26-46-94(87)112(101)125(3,4)105(140)49-20-10-9-11-21-50-106-126(5,6)113-95-47-27-25-43-88(95)54-62-102(113)141(106)74-32-33-76-166(149,150)151/h9-13,16-21,24-27,38-43,46-47,49-50,53-66,81-82,98-99H,14-15,22-23,28-37,44-45,48,51-52,67-80,83-84H2,1-8H3,(H8-2,133,134,135,136,137,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163)/t98-,99-/m0/s1
| Molecular Formula | C127H145ClF4N10O23S5 |
| Molecular Weight | 2451.335 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 7 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:06:38 GMT 2025
by
admin
on
Wed Apr 02 11:06:38 GMT 2025
|
| Record UNII |
S8N62H5A5W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2231255-31-3
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY | |||
|
171389998
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY | |||
|
12872
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY | |||
|
S8N62H5A5W
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY | |||
|
300000054557
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY | |||
|
C206872
Created by
admin on Wed Apr 02 11:06:38 GMT 2025 , Edited by admin on Wed Apr 02 11:06:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Consistent with numerous reports that cysteine cathepsin activity is overexpressed in multiple tumor types, VGT-309 has been found to label all tumor models tested to date.
IN-VITRO
|